TY  - JOUR

T1  - 2349: Selatogrel, a novel P2Y12 inhibitor for emergency use, achieves rapid, consistent and sustained platelet inhibition following single-dose subcutaneous administration in stable CAD patients

JO  - EUROPEAN HEART JOURNAL

UR  - https://eprints.whiterose.ac.uk/id/eprint/192451

PY  - 2019/10/21

AU  - Storey RF

AU  - Gurbel PA

AU  - James S

AU  - Ten Berg JM

AU  - Tanguay J-F

AU  - Bernaud C

AU  - Frenoux J-M

AU  - Hmissi A

AU  - Van Der Harst P

AU  - Van't Hof AWJ

AU  - Dangas GD et al

ED  - 

DO  - DOI: 10.1093/eurheartj/ehz748.0136

PB  - Oxford University Press

VL  - 40

IS  - Suppl 1

SP  - 1355

EP  - 1355

Y2  - 2024/12/26

ER  -